PMAQX
Price
$45.47
Change
-$0.16 (-0.35%)
Updated
Sep 20 closing price
RRMGX
Price
$97.44
Change
-$0.69 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

PMAQX vs RRMGX

Header iconPMAQX vs RRMGX Comparison
Open Charts PMAQX vs RRMGXBanner chart's image
Principal MidCap R6
Price$45.47
Change-$0.16 (-0.35%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth R
Price$97.44
Change-$0.69 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PMAQX vs RRMGX Comparison Chart
Loading...
VS
PMAQX vs. RRMGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMAQX is a Buy and RRMGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 31.4B vs. PMAQX (27.7B). PMAQX pays higher dividends than RRMGX: PMAQX (0.10) vs RRMGX (0.00). PMAQX was incepted earlier than RRMGX: PMAQX (8 years) vs RRMGX (22 years). RRMGX is a more actively managed with annual turnover of: 21.70 vs. PMAQX (10.10). PMAQX has a lower initial minimum investment than RRMGX: PMAQX (0) vs RRMGX (2500). PMAQX annual gain was more profitable for investors over the last year : 31.19 vs. RRMGX (13.62). PMAQX return over 5 years is better than : 49.09 vs. RRMGX (9.23).
PMAQXRRMGXPMAQX / RRMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years22 years-
Gain YTD18.5978.605216%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets27.7B31.4B88%
Annual Yield % from dividends0.100.00-
Returns for 1 year31.1913.62229%
Returns for 3 years8.96-16.28-55%
Returns for 5 years49.099.23532%
Returns for 10 yearsN/A33.74-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OII26.020.16
+0.62%
Oceaneering International
COTY9.19-0.20
-2.13%
COTY
CLCO11.05-0.30
-2.64%
Cool Company Ltd
QLGN0.17-0.01
-3.55%
Qualigen Therapeutics
PRPH2.34-0.17
-6.77%
ProPhase Labs